“…Preclinically, mesoscopic PAI has been used to monitor the development of vasculature in several tumour xenograft models [17] , [18] , [19] and can differentiate aggressive from slow-growing vascular phenotypes [19] . Studies to-date, however, have been largely restricted to qualitative analyses due to the challenges of accurate 3D vessel segmentation, quantification and robust statistical analyses [17] , [20] , [15] , [18] , [19] , [21] . Instead, PAI quantification is typically manual and ad-hoc , with 2D measurements often extracted from 3D PAI data [17] , [20] , [22] , [19] , [23] , reducing repeatability and comparability across datasets.…”